AAAAI funding opportunities - 04/08/21
Doi : 10.1016/j.jaci.2021.05.019
Mitchell H. Grayson, MD ⁎ 
Nationwide Children’s Hospital and The Ohio State University, Columbus, Ohio
∗Corresponding author: Mitchell H. Grayson, MD, Division of Allergy and Immunology, Nationwide Children’s Hospital, 700 Children’s Dr, Columbus, OH 43205.Division of Allergy and ImmunologyNationwide Children’s Hospital700 Children’s DrColumbusOH43205
Key words : Funding, grants, research support, allergy, immunology
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: M. H. Grayson has served on advisory boards for DBV and GlaxoSmithKline, and he serves as chair of the grants committee of the American Academy of Allergy, Asthma & Immunology, as well as faculty development awards chair and member of the American Academy of Allergy, Asthma & Immunology Foundation Council. |
© 2021
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 148 - N° 2
P. 351-354 - août 2021 Retour au numéro
Article précédent
- Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease
- Kathleen M. Buchheit, Tanya M. Laidlaw, Joshua M. Levy
- New ideas: Food allergy stems from food quality sensing
- M. Cecilia Berin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?